Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.verified

SPPI

Price:

$1.025

Market Cap:

$210.38M

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license...[Read more]

Industry

Biotechnology

IPO Date

1996-09-26

Stock Exchange

NASDAQ

Ticker

SPPI

The PE Ratio as of June 2024 (TTM) for Spectrum Pharmaceuticals, Inc. (SPPI) is -2.85

According to Spectrum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.85. This represents a change of 0.33% compared to the average of -2.84 of the last 4 quarters.

Spectrum Pharmaceuticals, Inc. (SPPI) Historical PE Ratio (quarterly & annually)

How has SPPI PE Ratio performed in the past?

The mean historical PE Ratio of Spectrum Pharmaceuticals, Inc. over the last ten years is -6.36. The current -2.85 PE Ratio has changed 4.37% with respect to the historical average. Over the past ten years (40 quarters), SPPI's PE Ratio was at its highest in in the June 2018 quarter at 39.12. The PE Ratio was at its lowest in in the June 2015 quarter at -47.72.

Quarterly (TTM)
Annual

Average

-6.36

Median

-6.12

Minimum

-17.68

Maximum

-0.86

Spectrum Pharmaceuticals, Inc. (SPPI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Spectrum Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 275.39%

Maximum Annual PE Ratio = -0.86

Minimum Annual Increase = -224.78%

Minimum Annual PE Ratio = -17.68

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.86-30.36%
2021-1.24-49.88%
2020-2.48-16.71%
2019-2.97-60.53%
2018-7.53-57.39%
2017-17.68275.39%
2016-4.71-38.88%
2015-7.70-21.46%
2014-9.8113.39%
2013-8.65-224.78%

Spectrum Pharmaceuticals, Inc. (SPPI) Average PE Ratio

How has SPPI PE Ratio performed in the past?

The current PE Ratio of Spectrum Pharmaceuticals, Inc. (SPPI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.53

5-year avg

-3.02

10-year avg

-6.36

Spectrum Pharmaceuticals, Inc. (SPPI) PE Ratio vs. Peers

How is SPPI’s PE Ratio compared to its peers?

Spectrum Pharmaceuticals, Inc.’s PE Ratio is greater than Selecta Biosciences, Inc. (-3.39), greater than Paratek Pharmaceuticals, Inc. (-3.05), greater than Corvus Pharmaceuticals, Inc. (-4.02), greater than Immutep Limited (-80.19), greater than Icosavax, Inc. (-8.27), greater than Ardelyx, Inc. (-22.49), greater than Zura Bio Limited (-3.43), less than Hepion Pharmaceuticals, Inc. (-0.15), less than AVROBIO, Inc. (2.11), less than Verastem, Inc. (-0.88), greater than Agios Pharmaceuticals, Inc. (-7.05), less than bluebird bio, Inc. (-1.34), greater than Intercept Pharmaceuticals, Inc. (-13.55), less than Karyopharm Therapeutics Inc. (-0.75), less than BioLineRx Ltd. (0), less than Lexicon Pharmaceuticals, Inc. (-0.98), less than Seres Therapeutics, Inc. (-2.33), less than ImmunityBio, Inc. (-1.25), greater than Gamida Cell Ltd. (-6.67), less than Rigel Pharmaceuticals, Inc. (-0.23), greater than Geron Corporation (-8.43), greater than ImmunoGen, Inc. (-14.59), greater than null (-122.93),

Build a custom stock screener for Spectrum Pharmaceuticals, Inc. (SPPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spectrum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spectrum Pharmaceuticals, Inc. (SPPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spectrum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Spectrum Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Spectrum Pharmaceuticals, Inc. (SPPI)?

What is the highest PE Ratio for Spectrum Pharmaceuticals, Inc. (SPPI)?

What is the 3-year average PE Ratio for Spectrum Pharmaceuticals, Inc. (SPPI)?

What is the 5-year average PE Ratio for Spectrum Pharmaceuticals, Inc. (SPPI)?

How does the current PE Ratio for Spectrum Pharmaceuticals, Inc. (SPPI) compare to its historical average?